William Go is listed as an executive officer on 3 SEC Form D filings by 2 issuers between Oct 2014 and Dec 2022: A2 Biotherapeutics, Inc. (Agoura Hills, CA — biotechnology — 2022; $71.6M reported sold to 28 investors) and Una Luna Verde, LP (Irvine, CA — commercial — 2014; $1.43M reported sold to 6 investors).
What this means 2 separate companies raised money with this person listed as executive officer, over about 8 years. Across those companies the filings report $73M sold in total.
Listed alongside Alexander Kamb (2 shared filings), David Goeddel (2 shared filings), David Lucas (2 shared filings), Helen Kim (2 shared filings), Jakob Loven (2 shared filings) and 5 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around William. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name listed in Key records below.
What this means 2 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for William Go and found 4 differences: Form D filed 17 days after the first sale; Offering amount changed between filings; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.